Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure.

MLA

Berthelot, Emmanuelle, et al. “Patients with Cardiac Amyloidosis Are at a Greater Risk of Mortality and Hospital Readmission after Acute Heart Failure.” ESC Heart Failure, vol. 10, no. 3, June 2023, pp. 2042–50. EBSCOhost, https://doi.org/10.1002/ehf2.14337.

APA

Berthelot, E., Broussier, A., Hittinger, L., Donadio, C., Rovani, X., Salengro, E., Megbemado, R., Godreuil, C., Belmin, J., David, J. P., Genet, B., & Damy, T. (2023). Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure. ESC Heart Failure, 10(3), 2042–2050. https://doi.org/10.1002/ehf2.14337

Chicago

Berthelot, Emmanuelle, Amaury Broussier, Luc Hittinger, Cristiano Donadio, Xavier Rovani, Emmanuel Salengro, Richard Megbemado, et al. 2023. “Patients with Cardiac Amyloidosis Are at a Greater Risk of Mortality and Hospital Readmission after Acute Heart Failure.” ESC Heart Failure 10 (3): 2042–50. doi:10.1002/ehf2.14337.